fludarabine has been researched along with Brain Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derlon, JM; Gourand, F; Guillouet, S; Kalaeva, D; Khokholova, E; Kobyakov, G; Maryashev, S; Pitskhelauri, D; Postnov, A; Potapov, A; Pronin, I; Pyzhik, E; Rizhova, M; Toutain, J; Usachev, D; Valable, S; Vikhrova, N | 1 |
| Ahluwalia, MS; Alban, TJ; Bayik, D; Cheng, F; Grabowski, MM; Hong, C; Horbinski, C; Hwang, TH; Khalil, AM; Kristensen, BW; Lathia, JD; Lauko, A; Lo, A; McGraw, M; Otvos, B; Park, C; Roversi, G; Silver, DJ; Sorensen, M; Vail, D; Vogelbaum, MA; Watson, DC; Zhou, Y | 1 |
| Doorduijn, JK; Lam, KH; van de Langerijt, B; van den Bent, MJ | 1 |
| Langiewicz, P; Rzepecki, P; Sarosiek, T; Szczylik, C; Zolnierek, J | 1 |
| Crowley, J; Eyre, HJ; Hynes, HE; Jaeckle, C; Pollock, TW; Stephens, RL; Taylor, SA | 1 |
2 trial(s) available for fludarabine and Brain Neoplasms
| Article | Year |
|---|---|
Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Transplantation Conditioning; Vidarabine | 2005 |
Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trial.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Drug Evaluation; Female; Glioblastoma; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Tomography, X-Ray Computed; Vidarabine | 1991 |
3 other study(ies) available for fludarabine and Brain Neoplasms
| Article | Year |
|---|---|
First-in-Man Noninvasive Initial Diagnostic Approach of Primary CNS Lymphoma Versus Glioblastoma Using PET With 18 F-Fludarabine and l -[methyl- 11 C]Methionine.
Topics: Adrenal Cortex Hormones; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Vidarabine | 2022 |
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Coculture Techniques; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunotherapy; Interleukin-1beta; Male; Mice, Inbred C57BL; Mice, Transgenic; Myeloid-Derived Suppressor Cells; Sex Characteristics; T-Lymphocytes; Vidarabine | 2020 |
EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immune System; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Vidarabine | 2011 |